Legal Representation
Attorney
Maury M. Tepper, III
USPTO Deadlines
Next Renewal Deadline
2149 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-05-27)
Due Date
May 27, 2031
Grace Period Ends
November 27, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
48 eventsDate | Code | Type | Description |
---|---|---|---|
May 27, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
May 27, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
May 7, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
May 7, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Apr 29, 2025 | ALIE | A | ASSIGNED TO LIE |
Apr 29, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Apr 29, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Apr 15, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Apr 11, 2025 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Mar 28, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Mar 28, 2025 | GNRT | O | NON-FINAL ACTION E-MAILED |
Mar 28, 2025 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN |
Feb 28, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
Feb 27, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Dec 17, 2024 | IUAF | S | USE AMENDMENT FILED |
Dec 17, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
Jul 3, 2024 | EX5G | S | SOU EXTENSION 5 GRANTED |
Jul 3, 2024 | EXT5 | S | SOU EXTENSION 5 FILED |
Jul 3, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Jul 3, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Dec 30, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Dec 28, 2023 | EX4G | S | SOU EXTENSION 4 GRANTED |
Dec 28, 2023 | EXT4 | S | SOU EXTENSION 4 FILED |
Dec 28, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Jul 1, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Jun 29, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED |
Jun 29, 2023 | EXT3 | S | SOU EXTENSION 3 FILED |
Jun 29, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Jan 4, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Jan 2, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED |
Jan 2, 2023 | EXT2 | S | SOU EXTENSION 2 FILED |
Jan 2, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Jul 5, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Jul 1, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED |
Jul 1, 2022 | EXT1 | S | SOU EXTENSION 1 FILED |
Jul 1, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Jan 4, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Nov 9, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Nov 9, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION |
Oct 20, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Oct 4, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Oct 4, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
Oct 4, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Oct 4, 2021 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
Oct 4, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
Oct 2, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
Jun 8, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Mar 12, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 035
Promoting awareness of patient support offerings for autoimmune and autoinflammatory diseases and disorders; business administration of reimbursement and healthcare benefit information for autoimmune and autoinflammatory diseases and disorders and their treatment
First Use Anywhere:
20210400
First Use in Commerce:
20210400
Class 036
insurance services, namely, benefits verification in the nature of insurance claims administration; providing online financial assistance with insurance benefits and coverage for health care providers and patients in the fields of autoimmune and autoinflammatory diseases and disorders
First Use Anywhere:
20210400
First Use in Commerce:
20210400
Class 041
Educational services, namely, conducting educational programs in the nature of webinars in the fields of autoimmune and autoinflammatory diseases and disorders and treatment and patient support options for these conditions
First Use Anywhere:
20210400
First Use in Commerce:
20210400
Class 044
Providing medical information for health care providers and patients in the fields of autoimmune and autoinflammatory diseases and disorders; medical support services, namely, providing healthcare information to patients and healthcare professionals in the fields of autoimmune and autoinflammatory diseases and disorders
First Use Anywhere:
20210400
First Use in Commerce:
20210400
Additional Information
Design Mark
The mark consists of the term "KINIKSA" above and left justified with the words "ONECONNECT" with the "E" in "ONE" linked to the "C" in "CONNECT"; the color gray represents shading and contrast only and is not a feature of the mark.
Translation
The wording "KINIKSA" has no meaning in a foreign language.
Classification
International Classes
035
036
041
044